GZMA and neoplasm: Granzyme A expression was reduced in both frequency and intensity in CD56dim NK cells from central tumor samples from patients with NSCLC compared with healthy blood controls, hinting at a release of granzyme A by NK cells within the tumor (Fig. 6h,i).